Skip to main content
. 2021 Jan 18;14(1):141–147. doi: 10.18240/ijo.2021.01.20

Table 1. Characteristics of the included studies.

Study Region Study design Complication type Age (y) Sex (M/F) BMI (kg/m2) HbA1c eGFR (mL/min/1.73 m) Smoking (%) Hypertension (%) Exercises (%) Drinking (%)
Gong 2010[35] China Case control DR(+) 56.95±12.66 1.67 NA 9.27±2.53 NA 25. 12 NA NA NA
DR(-) 49.85±10.62 2.73 NA 8.90±2.30 NA 26. 15 NA NA NA
Han 2015[18] Korea Case control DN 58 1.11 25.3 7.3 90.4 31.63 58 13.71 10.79
Sharma 2016[32] USA Case control DN 47 0.86 27.1 NA 100.3 25.37 23.08 79.26 81.74
Ricardo 2015[33] USA Case control DN 41.5 1 26.4 NA NA 51.6 20.4 NA NA
Song 2017[34] Korea Case control DR(-) 57±0.7 0.82 22.7±0.1 7.2±0.1 92.6 23.2 52.4 23.1 54.2
DR(+) 58.5±1.6 1.18 22.2±0.3 8.2±0.2 87.7 27.3 37.2 20 48.1
Amiri 2014[19] Iran Case control DR(-) 55.69±8.49 0.42 NA NA NA NA 28.17 NA NA
DR(+) 56.97±10.46 0.46 NA NA NA NA 26.87 NA NA
Nitta 2017[17] Japan Case control DR/DN (+) 55.1±9.3 1.72 24.0±3.9 8.7±1.8 NA 42.6 NA NA NA
DR/DN (-) 52.4±10.3 1.44 23.9±3.9 7.7±1.5 NA 38 NA NA NA
Veena 2018[36] India Prospective cross-sectional study DR(-) 30-65 2.57 NA NA NA NA NA NA NA
DR(+)

NA: Not accessible; BMI: Body mass index; eGFR: Estimated glomerular filtration rate; HbA1c: Hemoglobin A1c.